Carlyle Group to buy 20% stake in Piramal Enterprises’ arm

27 Jun 2020 Evaluate
CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, an investment fund managed and advised by affiliated entities of The Carlyle Group Inc. has agreed to invest fresh equity capital for a 20% stake in Piramal Enterprises’ wholly owned subsidiary -- Piramal Pharma. The estimated equity capital investment in Piramal Pharma would amount to over Rs 3,700 crore. The final amount of equity investment will depend on the net debt, exchange rate and performance against the pre-agreed conditions at the time of closing of the deal.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises Share Price

925.05 17.25 (1.90%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Bajaj Finance 6729.85
Shriram Finance 2502.00
Aditya Birla Capital 232.15
SBI Cards AndPayment 751.70
Chola Invest & Fin. 1174.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.